Closed Loop secures £2.1m funding

The funding will support the development of a drug and digital approach to treat and manage major health conditions our society faces, starting with sleep disturbance and hypertension, with intentions to develop fully regulated, evidence-based drug and digital solutions for the NHS and international healthcare providers. The money was raised from Longwall Venture Partners, IQ Capital and Martlet, the investment arm of the Marshall of Cambridge group, with several leading Cambridge Angel investors taking part in the financing, including the well-known serial entrepreneur, Sherry Coutu. This most recent funding round has enabled the company to take offices in London, invest in technical product development, start clinical development and clinical trials as well as invest further in drug development.